Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion

OBJECTIVE: To determine if the early response assessments can predict the long-term efficacy of anti-vascular endothelial growth factor (VEGF) treatment for macular edema secondary to retinal vein occlusion (RVO-ME). METHODS: A retrospective study of patients with diagnosis of RVO-ME and intravitrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jialin, Ma, Huafeng, Zhou, Xiyuan, Wang, Qiuyu, Li, Weihou, Luo, Shuai, Cai, Chang, Li, Zefeng, Liu, Danning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959117/
https://www.ncbi.nlm.nih.gov/pubmed/35355596
http://dx.doi.org/10.3389/fmed.2022.851238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959117/
https://www.ncbi.nlm.nih.gov/pubmed/35355596
http://dx.doi.org/10.3389/fmed.2022.851238

Ejemplares similares